跳至主要内容
临床试验/NCT05021133
NCT05021133已完成不适用

Tele-Navigation of Lung Cancer Screening

University of Massachusetts, Worcester1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2023年6月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Completion of Tele-Navi LCS

研究概览

简要总结

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
50 Years 至 77 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Is eligible for LDCT for LCS follow-up
  • Has technology to complete study activities (e.g., video call visit)
  • English speaker
  • Has undergone LCS at UMMH
  • Is overdue for LDCT follow-up

排除标准

  • Has previous diagnosis of lung cancer
  • Has active cancer diagnosis
  • Is a nursing home or group care resident
  • Is pregnant

研究组 & 干预措施

Tele-Navi LCS

Other

Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS

干预措施: Tele-Navi LCS (Behavioral)

结局指标

主要结局

Completion of Tele-Navi LCS

时间窗: 30 days

Number of participants completed Tele-Navi LCS,

次要结局

  • Completion of Follow-up LCS(180 days)

研究者

发起方
University of Massachusetts, Worcester
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mayuko Ito Fukunaga

Assistant Professor of Medicine

University of Massachusetts, Worcester

研究点 (1)

Loading locations...

相似试验